Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2

Purpose The aim of this study was to determine whether biphasic calcium phosphate (BCP) bone substitute with two different concentrations of Escherichia coli-expressed recombinant human bone morphogenetic protein 2 (ErhBMP-2) enhances new bone formation in a standardized rabbit sinus model and to evaluate the concentration-dependent effect of ErhBMP-2. Methods Standardized, 6-mm diameter defects were made bilaterally on the maxillary sinus of 20 male New Zealand white rabbits. Following removal of the circular bony windows and reflection of the sinus membrane, BCP bone substitute without coating (control group) was applied into one defect and BCP bone substitute coated with ErhBMP-2 (experimental group) was applied into the other defect for each rabbit. The experimental group was divided into 2 subgroups according to the concentration of ErhBMP-2 (0.05 and 0.5 mg/mL). The animals were allowed to heal for either 4 or 8 weeks and sections of the augmented sinus and surrounding bone were analyzed by microcomputed tomography and histologically. Results Histologic analysis revealed signs of new bone formation in both the control and experimental groups with a statistically significant increase in bone formation in experimental group 1 (0.05 mg/mL ErhBMP-2 coating) after a 4-week healing period. However, no statistically significant difference was found between experimental group 1 and experimental group 2 (0.5 mg/mL ErhBMP-2 coating) in osteoinductive potential (P<0.05). Conclusions ErhBMP-2 administered using a BCP matrix significantly enhanced osteoinductive potential in a standardized rabbit sinus model. A concentration-dependent response was not found in the present study.

[1]  J. Park,et al.  Induction of bone formation by Escherichia coli-expressed recombinant human bone morphogenetic protein-2 using block-type macroporous biphasic calcium phosphate in orthotopic and ectopic rat models. , 2011, Journal of periodontal research.

[2]  Seong-Ho Choi,et al.  Bone formation of block and particulated biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in rat calvarial defects. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[3]  Seong-Ho Choi,et al.  Effects of biphasic calcium phosphate bone substitute on circumferential bone defects around dental implants in dogs. , 2011, The International journal of oral & maxillofacial implants.

[4]  Seong-Ho Choi,et al.  Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defects. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[5]  N. Lang,et al.  Early healing after elevation of the maxillary sinus floor applying a lateral access: a histological study in monkeys. , 2010, Clinical oral implants research.

[6]  D. Ribeiro,et al.  Immunoexpression of Cbfa-1/Runx2 and VEGF in sinus lift procedures using bone substitutes in rabbits. , 2010, Clinical oral implants research.

[7]  Ji‐Hyun Lee,et al.  The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. , 2010, Biomaterials.

[8]  Young-Kyun Kim,et al.  Sinus bone graft using new alloplastic bone graft material (Osteon)-II: clinical evaluation. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[9]  E. Schulten,et al.  The use of Straumann Bone Ceramic in a maxillary sinus floor elevation procedure: a clinical, radiological, histological and histomorphometric evaluation with a 6-month healing period. , 2010, Clinical oral implants research.

[10]  S. Jatana,et al.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). , 2008, The spine journal : official journal of the North American Spine Society.

[11]  Kyoo-Sung Cho,et al.  Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E. coli expression system , 2008 .

[12]  G. Daculsi,et al.  Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite , 2008, Journal of materials science. Materials in medicine.

[13]  Xing‐dong Zhang,et al.  Protein adsorption and zeta potentials of a biphasic calcium phosphate ceramic under various conditions. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  Pierre Layrolle,et al.  Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. , 2006, Biomaterials.

[15]  F. Wong-Staal,et al.  Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. , 2006, Protein expression and purification.

[16]  N. Wright,et al.  Bone morphogenetic proteins and spinal fusion. , 2002, Neurosurgical focus.

[17]  K. Ooya,et al.  Maxillary sinus augmentation model in rabbits: effect of occluded nasal ostium on new bone formation. , 2002, Clinical oral implants research.

[18]  U. Rinas,et al.  Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. , 2002, Journal of biotechnology.

[19]  K. Bessho,et al.  Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. , 2000, The British journal of oral & maxillofacial surgery.

[20]  M. Kumegawa,et al.  Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.

[21]  R. Jankowski,et al.  Histologic changes in the sinus membrane after maxillary sinus augmentation in goats. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[22]  T. Yamamuro,et al.  Effect of sterilization on bone morphogenetic protein , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  C. Misch.  Contemporary Implant Dentistry , 1993 .

[24]  최성호,et al.  Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis. , 2012 .

[25]  P. Huddleston.  Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical Spine , 2007 .

[26]  H. Herkowitz,et al.  Alternatives to Autologous Bone Harvest in Spine Surgery , 1999 .

[27]  J D Mabrey,et al.  An interspecies comparison of bone fracture properties. , 1998, Bio-medical materials and engineering.